Gerald Beaney Purchases 20,182 Shares of CRISM Therapeutics Corporation (LON:CRTX) Stock

CRISM Therapeutics Corporation (LON:CRTX) insider Gerald Beaney bought 20,182 shares of the company’s stock in a transaction on Monday, April 7th. The shares were acquired at an average price of GBX 988 ($12.62) per share, for a total transaction of £199,398.16 ($254,789.37).

CRISM Therapeutics Price Performance

Shares of CRTX stock opened at GBX 8.06 ($0.10) on Wednesday. The business’s fifty day moving average price is GBX 7.23 and its 200 day moving average price is GBX 8.75. The firm has a market capitalization of £878,077.46, a PE ratio of -1.39 and a beta of 0.81. CRISM Therapeutics Corporation has a 1-year low of GBX 5 ($0.06) and a 1-year high of GBX 30.90 ($0.39).

About CRISM Therapeutics

CRISM Therapeutics Corporation has developed an innovative drug delivery technology to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy drugs.
ChemoSeed, CRISM’s lead product, can be implanted directly into the tumour or the resection margin following the removal of a tumour.